VERTEX PHARMACEUTICALS INC / MA
SEC 4 · Filed
0000875320-26-000104Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Feb 25, 2026
- Security
- Common Stock
- Shares
-
223
- Price per share
-
486.35
Structured facts
{
"code": "S",
"date": "2026-02-25",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Transaction made pursuant to Ms. Ambrose\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2025."
},
"owners": [
{
"cik": "0001856587",
"name": "Ambrose Kristen",
"roles": [
"officer"
],
"title": "SVP \u0026 Chief Accounting Officer"
}
],
"ownership": "D",
"post_shares": "6981",
"price": "486.35",
"row": 2,
"rule_10b5_1": "1",
"security": "Common Stock",
"shares": "223",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}Insider transactionsEvent date Feb 24, 2026
Payment of exercise price or tax by delivery of securities by Ambrose Kristen
- Security
- Common Stock
- Shares
-
546
- Price per share
-
485.11
Structured facts
{
"code": "F",
"date": "2026-02-24",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {},
"owners": [
{
"cik": "0001856587",
"name": "Ambrose Kristen",
"roles": [
"officer"
],
"title": "SVP \u0026 Chief Accounting Officer"
}
],
"ownership": "D",
"post_shares": "7204",
"price": "485.11",
"row": 1,
"rule_10b5_1": "1",
"security": "Common Stock",
"shares": "546",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}